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Matricellular proteins are secreted into the extracellular
environment, or matrix, but do not play a primary structural
role in this location. Rather, these proteins modulate cell
function by interacting with cell-surface receptors, pro-
teases, hormones, and other bioeffector molecules, as well
as with structural matrix proteins such as collagens. The
term ‘matricellular’ was introduced to explain the unusual
diversity of functions that were beginning to be recognized
in proteins such as thrombospondin-1(TSP-1), SPARC, and
tenascin-C. (Sage and Bornstein 1991; Bornstein 1995).
The intent of segregating this subclass of secreted proteins
was to emphasize that the extracellular environment was a
major factor in regulating their synthesis, a process that had
been termed ‘dynamic reciprocity’ at an earlier date
(Bornstein et al. 1982). A review that summarized many
of the considerations that led to the concept of matricellular
proteinswas published inMethods inCellBiology (Bornstein
2002).
In additional reviews (Bornstein 2001; Bornstein and
Sage 2002) some of the distinguishing characteristics of
matricellular proteins were summarized in greater detail.
These included: 1) high levels of expression during
development and in response to injury; 2) binding to many
cell-surface receptors, components of the extracellular
matrix, growth factors, cytokines, and proteases; 3) induction
of de-adhesion or counter-adhesion in contrast to the
adhesivity of most matrix proteins (Murphy-Ullrich 2001;
Liu et al. 2009), and 4) a grossly normal or subtle phenotype
that is observed in mice with a targeted disruption
(knockout) of some matricellular protein genes. The com-
plexity of the functions of most matricellular proteins results
from the fact that these functions are, in large part, contextual,
i.e. they derive from the different structural proteins, cell-
surface receptors, proteases, and cytokines with which these
proteins come in contact in the local environment of different
tissues.
The unexpected phenotypes of some matricellular
protein-null mice have provided clues to the functions of
matricellular proteins. Thus, for example, the abnormally
shaped and sized collagen fibrils observed in TSP-2-null
mice in skin and other connective tissues led to the
demonstration that TSP-2 functions as a clearance factor
for MMP2 in the pericellular environment (Yang et al.
2001). In turn, the elevated MMP2 levels in the pericellular
environment of TSP2-null mice reduced tissue transgluta-
minase activity and the collagen crosslinks generated by
this enzyme (Agah et al. 2005). As another example, the
cataracts and increased adipogenesis encountered in
SPARC-nullmiceledtoabetterunderstandingofextracellular
matrix assembly (Brekken and Sage 2000) and SPARC
signaling pathways (Nie and Sage 2009).
Although a useful review of the functions of a limited
number of matricellular proteins in bone biology has been
published (Alford and Hankenson 2006), and Sangaletti
and Colombo (2008) have surveyed the functions of
matricellular proteins in inflammation and cancer, this issue
of the JCCS provides a more comprehensive coverage of
the field and takes advantage of recent mechanistic
information that improves our understanding of how
matricellular proteins function.
Thus, for TSPs, Bornstein has described the mechanisms
that enable TSP-1 and TSP-2 to function as both angiogenic
and anti-angiogenic proteins, and the potential clinical
applications of these properties; Hankenson and Delany
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Lawler describes the effects of TSPs on the structure of the
extracellular matrix; MacLauchlan and Kyriakides review
the role of TSPs in wound healing, ischemia, and the
foreign body response; and Schellings et al. review the
roles of TSPs in cardiac remodeling.
For SPARC and members of the SPARC family,
Bradshaw discusses the role of SPARC in extracellular
matrix assembly; Arnold and Brekken consider the role of
SPARC as a regulator of tumorigenesis, and Nie and Sage
summarize the evidence for SPARC as an inhibitor of
adipogenesis.
Some matricellar proteins are represented by single
presentations. Lund et al. present the role of osteopontin
in inflammatory proceses; Midwood and Orend consider
the role of tenascin-C in tissue injury and tumorigenesis;
Norris et al. describe the many facets of the effects of
periostin on cardiac development, remodeling, and patho-
physiology ; Merline et al. present evidence for the
matricellular functions of small leucine-rich proteoglycans
(SLRPS), and Yanagisawa et al. present data supporting the
inclusion of fibulin-5 in the matricellular protein family.
Finally, Eroglu summarizes the evidence for the roles of
matricellular proteins in the development and function of
the nervous system.
Clearly, the articles mentioned above do not cover all the
proteins that are now considered to be matricellular.
Prominent among those not included in this review are
several members of the CCN (Cyr-61, Connective tissue
growth factor, and Nov family of proteins that were
recently reviewed (Chen and Lau 2009; Holburn et al.
2008; and Yeger and Perbal 2007), tenascin- X (Zweers et
al. 2004), the galectins (Elola et al. 2007), plasminogen
activator inhibitor type 1 (PAI-1) (Maquerlot et al. 2006),
and autotaxin (Dennis et al. 2008).
An issue that has not been addressed in the categoriza-
tion of matricellular proteins is whether to include matrix
proteins, the matricellular function of which, as defined
above, is revealed only when fragments of the proteins are
investigated. It is now commonly recognized that new
functions, not present in the intact protein, can be generated
by limited physiological proteolysis (Sage 1997; Davis et
al. 2000). However, it would seem preferable at this time, in
the interest of brevity, to limit our discussion to matrix
proteins with matricellular properties that are expressed in
the intact proteins.
A PubMed search of the literature, performed at the end
of the 2008 calendar year, revealed that there were 348
publications that used the term ‘matricellular’ in the title
and/or abstract since its first use in 1995. The increase in
recent years has been almost exponential, with 65 citations
listed during 2008. A number of these citations concern
proteins with credentials as matricellular proteins that are
incomplete or questionable, but it is reasonable to expect
that the list of matricellular proteins will grow as more
information is gathered about other extracellular proteins
with non-structural functions.
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